
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
Mark Stejbach, Merck
S
Mark Stejbach
VP, Managed Care Marketing, Merck
DOUBLE DUTY: Is helping build Merck's new healthcare model
OF NOTE: First non-finance person to run Merck's investor relations
On payers:
For many years, the success of the industry was at least in part driven by the inefficiency of the economic model of healthcare. In the short term, there's always more to be eked out from the current model—and I think some companies are going to run with that as hard and as long as they can. But in the long term, companies have to understand that the market is going to be increasingly influenced by the people who pay the bills—payers and consumers. In that way, pharma will start to become more like most other industries.
Mark Stejbach
Articles in this issue
almost 18 years ago
Mary Szela, Abbottalmost 18 years ago
Mightier Than the Swordalmost 18 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsalmost 18 years ago
Eric Floyd, Cephalonalmost 18 years ago
Nancy Phelan, Wyethalmost 18 years ago
Tightening the Chainalmost 18 years ago
Kurt Graves, Vertexalmost 18 years ago
Wendy Niebler, Shirealmost 18 years ago
Perfectly ImperfectNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.



